The largest database of trusted experimental protocols

Hmc 1 cells

Manufactured by Merck Group
Sourced in Germany

The HMC-1 cells are a type of immortalized mast cell line derived from a human mast cell leukemia patient. They exhibit characteristics of immature mast cells and are commonly used as a model system for studying mast cell biology and function.

Automatically generated - may contain errors

2 protocols using hmc 1 cells

1

Modulation of Inflammatory Responses in Keratinocytes and Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells (a human keratinocyte cell line) were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C in a 5% CO2 humidified atmosphere. The medium was changed every two days during incubation. Cells were made quiescent by starvation in serum-free medium for 24 h, pretreated with ADM (10, 30 μM) or DEX (10 μM) for 1 h, and then stimulated with TI (TNF-α/IFN-γ, 10 ng/ml of each) for the indicated times. ADM was prepared by mixing the three compounds at a concentration of 10 μM each in DMSO. For example, “ADM 30 μM” means a composition containing 10 μM of arctigenin, hederagenin, and baicalein, respectively.
HMC-1 cells (a human mast cell-line) were obtained from Merck Millipore (Darmstadt, Germany) and cultured in IMDM supplemented with 10% FBS, 1% penicillin-streptomycin, 1.2 mM 1-thioglycerol, at 37°C in 5% CO2 humidified atmosphere. HMC-1 cells were incubated with 10 μM SP for 48 h. Then, ADM (10 or 30 μM) or DEX (10 μM) were added 1 h prior to 1 nM CRH treatment. Cells were incubated for another 24 h.
+ Open protocol
+ Expand
2

Modulation of Inflammatory Responses in Skin and Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A human immortalized keratinocyte cell line (HaCaT cells) was provided by Korea Institute of Oriental Medicine (Daegu, Korea) and maintained in high glucose DMEM medium (Welgene Inc., Gyeongsangbuk, Korea) supplemented with 10% FBS and 1% antibiotics (10,000 μg/ml of streptomycin and 10,000 units/ml of penicillin) (Invitrogen Inc., Carlsbad, CA, USA) and incubated at 37°C with 5% CO2. After serum-starvation for 24 h, HaCaT cells were pretreated with SMGGT (10 and 100 μg/ml), puerarin, paeoniflorin (1, 10 μM), or DEX (10 μM) for 1 h and then incubated with TNF-α and IFN-γ (TI; 10 ng/ml each) for the indicated times. Recombinant human TNF-α and IFN-γ were obtained from Koma Biotech Inc. (Seoul, Korea).
A human mast cell line (HMC-1 cells) was purchased from Merck Millipore (Darmstadt, Germany) and grown in Iscove's Modified Dulbecco's Medium (IMDM) (Merck Millipore) supplemented with 10% FBS, 1% antibiotics, and 1.2 mM 1-thioglycerol (Sigma-Aldrich, St. Louis, MO, USA), at 37°C with 5% CO2. The cells were stimulated with 10 μM SP for 48 h, followed with 1 nM CRH for 24 h, as described previously [21 (link)]; SMGGT (10 and 100 μg/ml), puerarin, paeoniflorin (1, 10 μM), or DEX (10 μM) was treated 1 h before addition of CRH. SP and CRH were obtained from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!